Governor McMaster Issues Proclamation Recognizing South Carolina Life Sciences Week to Celebrate State’s Fastest-Growing IndustryGovernor salutes industry as record-setting SC life sciences conference starts see more
In recognition of the importance of the life sciences industry in South Carolina, Governor Henry McMaster has issued a proclamation recognizing February 21-25, 2022 as South Carolina Life Sciences Week in the Palmetto State.
Governor McMaster issued the proclamation just as SCBIO organizers are putting finishing touches on the largest-ever life sciences gathering ever held in the state. More than 500 registrants live and virtual from across America and around the globe will attend the SCBIO-led gathering of South Carolina’s life sciences community this week in Charleston – and will celebrate the contributions of its 700+ organizations in helping America and the world overcome the challenging COVID-19 pandemic.
In his proclamation, Governor McMaster highlighted the rapid growth of the cutting-edge industry in South Carolina and its reputation as an emerging force in life sciences. He specifically cited the industry’s efforts in workforce development, its emerging role in research and development, and its ability to attract high quality and high-paying jobs and investment to the Palmetto State.
Governor McMaster issued the proclamation as hundreds of life science executives from 27 states and six countries prepare to assemble in Charleston, SC for SCBIO 2022: The Life Sciences Conference of South Carolina. Charleston and the Lowcountry feature a strong concentration of life science companies, while the industry boasts life sciences organizational presence in 42 of South Carolina’s 46 counties. Among more than 35 featured presenters at the conference will be BIO’s global CEO Dr. Michelle McMurry-Heath, Clemson University President Jim Clements, PhRMA executive Courtney Christian, Nephron Pharmaceuticals CEO Lou Kennedy, and SC Commerce Secretary Harry Lightsey III. SCBIO President and CEO James Chappell will deliver a highly anticipated State of the Industry address on the opening day of the Conference.
Among many highlights of the Conference will be the unveiling of a new Economic Impact Study for the state’s life sciences industry, a study last conducted in 2017 that revealed the sizable impact of the industry, including an$11 billion economic impact, more than 700 firms, and over 33,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. Officials familiar with the just-completed study indicate the new results could be “significantly higher” despite the pandemic’s economic body blows.
Life sciences today represents a key economic development focus for the state, with strong life science recruiting initiatives led by the South Carolina Department of Commerce and other regional economic development teams. Governor McMaster issued an Executive Order in April 2021 for the state to make life sciences a strategic focus for South Carolina in its recruiting and economic development priorities.
“Life sciences is a major driver of South Carolina’s economy today, and this conference is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and country,” noted SCBIO President and CEO James Chappell. “We’re honored by Governor McMaster’s recognition and appreciate his personal support for the contributions that life sciences are making to improve quality of life, care and economic standing for South Carolina citizens.”
For additional information on SCBIO or to register for SCBIO 2022, visit www.SCBIO.org.
WHEREAS, South Carolina has cultivated a cutting-edge life sciences sector with an annual economic impact of more than 25 billion dollars; and
WHEREAS, more than 1,000 firms and over 87,000 professionals are involved in the research, development, and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products; and
WHEREAS, since 2017, the life sciences sector has become South Carolina’s fastest-growing industry, with employment growing at double the rate of South Carolina’s economy; and
WHEREAS, SCBIO is the organization exclusively focused on attracting new life science sector jobs and investment to South Carolina; and
WHEREAS, during the COVID-19 pandemic, more than 100 life sciences organizations across South Carolina worked together to support and promote the procurement and distribution of personal protective equipment, support and implement COVID-19 testing, and expedite health solutions for our citizens; and
WHEREAS, in collaboration with the South Carolina Department of Commerce and SCBIO, South Carolina’s economic development recruitment efforts shall include an enhanced emphasis and focus on attracting, building, advancing, innovating, and growing existing and new life sciences businesses in the state.
NOW, THEREFORE, I, Henry McMaster, Governor of the great State of South Carolina, do hereby proclaim February 21 – 25, 2022, as
SCBIO life sciences week
throughout the state and encourage all South Carolinians to recognize and appreciate the many contributions of the life sciences industry to South Carolina’s health and economic prosperity.
SCBIO Issues 2021 Annual Report as Attendees Gather for 2022 Life Sciences Conference of South CarolinaDownload and review your complimentary copy of the 2021 SCBIO annual report now. see more
The Board and staff of SCBIO have issued their 2021 Annual Report in advance of the organization hosting SCBIO 2022: The Life Sciences Conference of South Carolina, which begins this week.
More than 500 live and virtual attendees will participate in the record-setting conference, which features more than 35 speakers, major economic development announcements, hundreds of partnering sessions and more.
The annual report contains key statistical updates on the growth of the life sciences industry, its economic impact on the state, major milestones of the past 12 months, trends and much more. Download your complimentary copy here.
SCBIO not playing games with workforce development see more
For those raising the next generation of workforce talent at home, it may be a no-brainer that 12-year-olds are more likely to learn about future career opportunities from TikTok, YouTube or Duolingo than LinkedIn.
Yet much of the online conversation surrounding new career developments remains resigned to the adult corporate sphere.
SkillsGapp, a Greenville-based app platform, seeks to broaden that conversation to include the audience making those first steps toward a career.
The startup offers apps for a variety of fields including skilled trades, aerospace and advanced manufacturing, as well as the fast-growing life science industry. SkillsGapp’s newest app, RadLab, gamifies life science careers for middle schoolers.
“We understand, and the industry understands, that we got to fill that pipeline,” SCBIO CEO James Chappell told SC Biz News, adding that middle school is a key time in the development of interests that later feed into career paths. “So we want to catch them early enough.”
The free game allows students to try a number of jobs — ranging from the R&D side of the equation to manufacturing to nursing — on for size and level up through a variety of challenges. Teens can test new medicines, obtain Food and Drug Administration approval, manage the manufacturing of products and use them to treat hospital patients.
Geofencing will link players to the non-virtual world of life sciences during game play through prompts that offer information on local industries and education pathways into the careers they are sampling.
“They will not only be playing the game and understand what it means to go in these different career paths, but they’ll also have a pop-up that says, if you’re in Columbia, did you know that Nephron is in your area and they have an average of this amount per year, or if they drive by another company, in the Upstate, it’s the same thing,” Chappell said. “They’re getting life science skills without even realizing it, and also learning about these companies and the specific opportunities that there are here.”
If an educational program, such as a certificate at a local tech school, isn’t available within a certain radius, the mileage limit will expand and alert players to the nearest programs.
“It’s really helping that player and that student navigate their own interests, which Gen Z does, and then be able to flip the conversation,” Zwolinski said.
She hopes that students we be more likely to tell their parent or guidance counselor or teacher about careers that spark their interest and how to pursue them instead of the other way around.
Both in-game and out-of-game incentives help sweeten the pot.
RadLab, a single-player game, drives up the competition through a leaderboard and badges that teens can earn as they navigate a “skill tree.” There is also an in-game resume that can be used to inform apprenticeship or internship decisions come high school.
Other competitions could earn students the opportunity to observe a surgery, tour a lab, host a pizza party or win a free semester at a technical college.
“We’re giving them real-world experiences to connect them out of game, but making them fun, making them exciting to align with the in-game play,” Zwolinski said.
The game’s strategic planning phase launched in April and is set to conclude later in May. In the meantime, Greenville’s Dr. Phinnize J. Fisher Middle School and the Governor’s School of Science and Mathematics is piloting the program, but Zwolinski expects to form partnerships with institutions and summer camps across the state, especially Allendale County in the Lowcountry.
A soft launch is scheduled for this summer and a 12-month deployment plan, including a launch poster designed by students at Fisher Middle School, is slated to begin this fall.
New HQ set for life science consultancy see more
EverGlade Consulting has opened an office location in Charleston, South Carolina as part of its expansion into the Southeast, formalizing its headquarter's location.
EverGlade recently announced the appointment of Charleston resident Andrew Stiles as Principal in the group and will use this new location as a means of recruiting local talent and new clients into the firm. The company currently works with a variety of life sciences and defense companies in the Southeast and plans to use its new Charleston location to further expand into this important region.
"While EverGlade has its roots in Washington, D.C. as a virtual company, Charleston is home," commented Daniel Paterson, Chief Operating Officer and Charleston resident. "The industrial base matches the profile of companies we are hoping to attract. New and fast-growing companies in the life sciences, defense, and technology sectors are choosing the Southeast and cities like Charleston. As such, we felt we needed a physical presence to grow our business alongside these exciting companies and truly have boots-on-ground where the novel technology and ideas are being developed."
"Since 2017 South Carolina is a clear leader in the growth of life sciences in the Southeast, and the addition of professional service firms like EverGlade to our state's ecosystem is key in continuing to support the sector and its growth," noted SCBIO CEO James Chappell.
EverGlade expects to officially open the office on April 4. The company plans to recruit for positions in regulatory affairs, quality assurance, program management, project management, and government contract administration and compliance as part of its Southeast expansion plan.
EverGlade Consulting is a consulting firm with employees across the country, that helps clients navigate the federal landscape. We are inspired by technology-driven companies whose focus is to secure non-dilutive funding from the federal government. We offer services ranging from opportunity identification and proposal support through post-award contract management and compliance with federal regulations at agencies including ASPR, BARDA, NIH, CDC, DHS, FEMA, JPEO, DTRA, DLA, and DARPA.
For additional information about EverGlade Consulting, visit: https://www.EverGlade.com.
Rebuttal to a factually inaccurate and decidedly slanted article about a member of SC life sciences see more
South Carolina is blessed with over 1,000 life sciences organizations, engaged in biotechnology and pharmaceuticals to medical devices and health IT. Never was this more important than during the pandemic, when millions were hospitalized and too many lives lost.
As neighbors fell ill, our industry -- including Charles River Laboratories professionals -- stepped up. Over 100 organizations produced PPE, tested for COVID-19, conducted vaccine clinical trials, and expedited health solutions. Gov. McMaster expressed appreciation by declaring Life Sciences Week in South Carolina.
As our state’s voice of life sciences, SCBIO wishes your “Monkeys & Blood” article had highlighted Charles River’s globally celebrated work that helps save millions of lives and improves patient safety.
Carefully obtained from Atlantic horseshoe crabs by Charles River professionals, Limulus amebocyte lysate (LAL) is critical to saving lives of patients everywhere. The unique, natural substance is used to test every injectable pharmaceutical, implantable medical device, and approved COVID-19 vaccine against contamination. Without it, endotoxins could enter the body and produce life-threatening sepsis.
For decades, Charles River has protected and nurtured our crab population. Its microbial testing is considered best-in-class by scientists globally. And with synthetic LAL neither readily available nor FDA-licensed, industry experts decline its sole use because the safety of IVs, vaccines and more would not be assured as with natural LAL.
Charles River and our life sciences ecosystem make tremendous contributions to our state and the health of mankind. Their lifesaving medical innovations should be celebrated.
James Chappell, CEO of SCBIO
Talented students honored at SCBIO 2022 life sciences conference see more
Two Clemson University students placed in SCBIO’s Challenge Accepted video competition for their videos presenting research from the lab of Ramakrishna Podila, an associate professor in the Department of Physics and Astronomy, on inexpensive COVID-19 and tuberculosis sensors using smartphones.
Participating students created videos no longer than three minutes highlighting life science innovation or research in South Carolina. The videos were judged on the content, production quality and creativity, and potential impact of their work on the industry.
The competition was part of SCBIO’s annual conference held February 22-24 in Charleston. SCBIO is a member-driven organization formed to advance South Carolina’s life science industry through collaboration, advocacy and resource support. It provided students a creative way to engage with the state’s life sciences ecosystem, said Zach Hargett, SCBIO’s programming and special projects director.Dylan Carroll
“Connecting students with companies in South Carolina is a critical part of developing our state’s workforce. The SCBIO student video competition is a unique way to highlight several of South Carolina’s best and brightest minds in front of hundreds of industry leaders throughout the state and country,” Hargett said. “We believe programs like this, our student membership program and student-industry engagement sessions are giving both students and companies a unique platform to get the most out of South Carolina’s life sciences ecosystem.”
The COVID-19 pandemic illustrated the need for access to convenient, inexpensive testing that facilitates rapid diagnosis to help stop the spread of diseases, Carroll said.
Carroll’s video focused on how Analtye-induced disruption in luminance quenching (AIDLuQ) technology is used as a sensor. AIDLuQ uses regular printer paper coated with graphene particles that a smartphone could read to detect disease.
Access to testing
“As we’ve seen during the COVID-19 pandemic, there’s been lots of problems with access to testing and how long it takes to get results,” Carroll said. “With Dr. Podila’s research, you could get test results in under 15 minutes at home using your smartphone. That would solve a lot of problems with access to testing.”
Rowland’s video focused on research that turns a smartphone into a spectrogram to detect tuberculosis, a bacterial infection that attacks the lungs. Tuberculosis is the leading infectious disease killer in the world.Ramakrishna Podila
“Often, tests have to be done by trained medical professionals. That can be a problem,” Rowland said.
While some people would think lack of access to medical tests would be a problem in the developing world, it also affects countries like the U.S., Podila said.
“While the COVID test is free, if there is any other test, you pay a minimum of 100 bucks. You have to go to the doctor, and that’s another 100 bucks for the copay. You have to make an appointment, which can take time,” Podila said. “The whole idea behind this research is to take existing technology, in this case a smartphone, to allow for accessible health care.”
The sensors are ready for human clinical trials, Podila said. Bharat Biotech, a COVID-19 vaccine manufacturer in India, has inquired about using the sensors developed by Podila’s lab to check antibody levels of people in their clinical trials.
Explaining the science
Rowland said the most significant challenge he faced when producing his video was to explain the technology so non-scientists could understand.
“Often, the biggest issue in science is explaining research in a way that’s not science,” he said. “Time was the biggest challenge in making the video because you have to take this research that has taken months, or even sometimes years, to do and condense it down into a marketable video that somebody could watch and say, ‘I can help on that project.’”Alan Rowland
Carroll said he wanted his video to grab attention, so he bought a $20 animation software program.
“Whenever I’ve needed to watch science videos in the past, it was always some sort of animated video that grabbed my attention,” he said. “I wanted to make it anecdotal, something that could relate to everyone. I wanted it to grab the attention of anyone who’s ever traveled and needed medical care. Once I grabbed their attention, I wanted to bring in the science aspect of it and how the device could benefit them and society.”
SCBIO CEO James Chappell said, “The SCBIO student video competition is a unique way to cultivate relationships between life science industry leaders and some of our most talented students. This relationship leads to career opportunities for the individual students and establishes comfort and familiarity between the companies and schools, leading to a more long-term talent pipeline.”
One of Podila’s main goals is to train students to communicate.“Knowledge is its own reward,” Podila said. “We not only teach them physics, we not only teach them science, but we also teach them how to communicate effectively,” he said. “I’m happy Dylan and Alan put in the effort and won the contest. But for me, they already won when they made the video because they learned something. That was the real prize.”
Business is booming across South Carolina... and the future is bright. see more
John Wall authored an article highlighting the positive economic development outlook for South Carolina, which was published in the March 2022 issues of Integrated Media Publishing’s three monthly business publications: Charleston Business, Columbia Business Monthly, and Greenville Business Magazine.
“The future is bright for South Carolina, her people, and the economy,” Wall said before detailing how the state’s economic foundation has primed the business landscape for sustained success in many areas.
South Carolina’s massive port activity has positioned the state for growth in several industries thanks to its global connections and international trade routes. In addition to the environmentally driven sectors like timber companies and agribusiness, the Palmetto State has reinvented itself for the modern business environment with success in the evolving textile industry, as well as manufacturing and life sciences sectors.
Wall noted that the recipe for sustained success extends beyond the foundational advantage already in place and into the effective leadership in place to continue moving the state into the future. “We have amazing industry-specific organizations, such as the South Carolina Manufacturers Alliance, which has worked tirelessly for over a century to advance manufacturing and the business community,” he said. “Newer organizations like the South Carolina Boating & Fishing Alliance have made major waves in promoting the burgeoning boating and fishing industry in South Carolina.”
Additionally, Wall noted the importance of state agencies like the South Carolina Department of Commerce that do a great job in supporting existing businesses and recruiting new ones to the state, especially with effective leadership from the Department’s new Secretary, Harry Lightsey.
Global BIO CEO to Keynote 2022 SC Life Sciences Conference; Registration Soars, Exhibit Hall Nears Sell-Out in CharlestonOver 140 organizations and hundreds of nation’s industry leaders to gather Feb. 22-24 see more
SOUTH CAROLINA – January 24, 2022 – Global President & CEO of BIO, Dr. Michelle McMurry-Heath, will be live in Charleston to keynote the opening day of SCBIO 2022, the Life Sciences Conference of South Carolina, conference organizers have announced.
Dr. McMurry-Heath will join more than 30 additional speakers as featured presenters at the largest life sciences conference in Palmetto State history as the event convenes both in-person and virtually February 22-24 at the Gaillard Center in the heart of Charleston, S.C.
Themed “Challenge Accepted,” the 2-day SCBIO 2022 event will feature national speaker sessions including Transformational Technologies, Next Generation Patient Care, Ensuring Opportunity for All, and Embracing Collaboration & Innovation – fundamental forces driving the state’s fastest growing industry: life sciences.
Dr. McMurry-Heath assumed the leadership of BIO as just its third President and CEO in June, 2020. A medical doctor and molecular immunologist by training, she stewards the world’s largest biotechnology advocacy group, representing 1,000 life sciences companies and organizations from 30 countries. The organization’s mission is to support companies that discover and deploy scientific breakthroughs that improve human health, environmental stewardship, and sustainable agriculture.
She has championed a focus on broadening access to scientific progress so more patients from diverse backgrounds can benefit from cutting-edge innovation, clinical trials and healthcare funding, a topic she terms “the social justice issue of our age.” She joined BIO from Johnson & Johnson where she served as Global Head of Evidence Generation for Medical Device Companies and then Vice President of Global External Innovation and Global Leader for Regulatory Sciences. She was also instrumental in bringing J&J’s incubator, JLabs, to Washington, DC. She led a global team of 900 with responsibilities in 150 countries around the globe.
Presented by sponsoring organizations Nephron Pharmaceuticals, Vikor Scientific, Revaly (a Zverse Solution) and other top organizations, the conference is expected to draw a sell-out attendance of 450 in person attendees and hundreds more virtually to Charleston. Attendees will be required to present proof of vaccination or a negative Covid test result within 72 hours of arrival before being admitted.
Among other top speakers scheduled to appear include FDA Associate Director of the CDER Drug Shortage Staff Valerie Jensen MUSC Health CEO Dr. Pat Cawley, Velocity Clinical Research executive Steve Clemons, and USC Provost Dr. Stephen Cutler, Clemson University President James Clements, Commerce Secretary Harry Lightsey III, Nephron CEO Lou Kennedy, PhRMA Senior Policy Director Courtney Christian, Georgia Health Information Network Director Dr. Denise Hines, State Epidemiologist Dr. Linda Bell and more than 20 others.
National economist Dr. Joseph Von Nessen of University of South Carolina’s Moore School of Business will report findings of a just-completed economic impact study of the state’s life sciences cluster, last analyzed in 2017, while SCBIO CEO James Chappell will present a State of the Industry presentation on the outlook for South Carolina’s $12 billion – and fastest-growing – industry.
The conference features an expanded – and nearly sold out -- exhibit hall showcasing scores of life sciences industry businesses, institutions of higher learning and essential support industry partners from across America. The conference also features presentation of the prestigious Pinnacle Awards by South Carolina Life Sciences to the outstanding 2021 Organization of the Year, Individual of the Year, and Rising Star under 40 years of age, as well as a new recipient into the SC Life Sciences Hall of Fame.
Hundreds of in-person and virtual attendees will take advantage of meetings and connection sessions through the conference’s Partnering Portal as well as at two gala receptions planned for attendees.
Registration to attend SCBIO 2022 is now open at the 2022 Annual Conference section of www.scbio.org for interested companies, industry supporters, students interested in life sciences, faculty and teachers. Limited Exhibit space and sponsorships are still available by inquiring at email@example.com.
The 2-day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Already committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, R&D, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more.
SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 700 firms directly involved and over 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products. In 2021, Governor Henry McMaster issued an Executive Order making it a state priority to continue to grow and expand the life sciences industry in the Palmetto State.
Among 140 leading biotech and med-tech industry brands participating in the conference are Nephron Pharmaceuticals, Vikor Scientific, Zverse, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Rhythmlink, SoftBox Systems, ZEUS, Patheon Thermo Fisher, Abbott, Alcami and more. All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, South Carolina Hospital Association and others.
For additional information on SCBIO or to register for SCBIO 2021, visit www.SCBIO.org.
Hundreds of nation’s industry leaders to gather for strategic partnership development, insights see more
With the biggest story of 2021 – the global COVID-19 pandemic – serving as a backdrop, the largest life sciences conference in Palmetto State history will convene both in-person and virtually February 22-24 to address how South Carolina and America are accepting the challenge of achieving health and prosperity for all, South Carolina life sciences industry officials have announced.
Themed “Challenge Accepted,” the 2-day SCBIO 2022 event will feature national speaker sessions on Transformational Technologies, Next Generation Patient Care, Ensuring Opportunity for All, and Embracing Collaboration & Innovation – fundamental forces driving the state’s fastest growing industry: life sciences.
Currently listed as a $12 billion industry, national economist Dr. Joseph Von Nessen of University of South Carolina’s Moore School of Business will report findings of a just-completed economic impact study of the state’s life sciences cluster, last analyzed in 2017.
FDA Associate Director of the CDER Drug Shortage Staff Valerie Jensen is the first announced featured major speaker for the 2-day conference, addressing the gathering in a Program “Challenge Accepted: Delivering Next Generation Care to Patients Now.” A trained clinical pharmacist, Captain Jensen was one of the initial developers of FDA’s Drug Shortage Program and was named Associate Director in 2012. She continues to manage the Drug Shortage Staff at FDA. Joined by MUSC Health CEO Dr. Pat Cawley, Velocity Clinical Research executive Steve Clemons, and USC Provost Dr. Stephen Cutler, the panel will focus on the industry’s success in to expediting development of medicine, devices, technologies and vaccines in record time and with startling efficacy – and what it means for care around the world going forward.
Captain Jensen will be joined by more than 25 additional presenters and honorees at SCBIO 2022, which brings together leaders and executives from life science organizations across the nation to South Carolina. In deference to the pandemic, FDA protocols on safety are being rigorously adhered to and events are also being presented and distributed virtually, organizers revealed.
The conference will feature a significantly expanded exhibit hall showcasing scores of life sciences industry businesses, institutions of higher learning and essential support industry partners from across America, as well as presentation of the prestigious Pinnacle Awards by South Carolina Life Sciences to the outstanding 2021 Organization of the Year and Individual of the Year. Also to be honored with Pinnacle Awards will be an inductee into the SC Life Sciences Hall of Fame, and an award for an industry Rising Star under 40 years of age.
New SCBIO CEO James Chappell will deliver a highly anticipated “State of South Carolina’s Life Sciences Industry” address, while hundreds of in-person and virtual attendees will take advantage of meetings and connection sessions through the conference’s Partnering Portal. Additional speakers will be announced shortly, as well as posted online.
Registration to attend the 2-day conference is now open online. For more details, visit the 2022 Annual Conference section at www.scbio.org. Registration and exhibiting are free to many SCBIO investors. Early bird general admission pricing provides significant discounts to interested companies, industry supporters, students interested in life sciences, faculty and teachers. Limited Exhibit space and sponsorships are also available by inquiring at firstname.lastname@example.org.
The 2-day conference annually draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion. Already committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, R&D, pharmaceuticals, diagnostics and testing, digital health and health IT, bio-ag and more.
SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state. The industry has more than 700 firms directly involved and over 43,000 professionals employed directly or indirectly in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products. In early 2021, Governor Henry McMaster issued an Executive Order making it a state priority to continue to grow and expand the life sciences industry in the Palmetto State.
“Life sciences is a major driver of South Carolina’s economy, and this conference’s growth is testament to the industry’s surging impact, reach and rapidly rising economic significance in our state and region,” noted SCBIO President and CEO James Chappell. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, this sector has tremendous growth potential, and we’re excited to showcase top companies, research universities and leaders from across our state and country at SCBIO 2022.”
Among leading biotech and med-tech industry brands participating in the conference are Nephron Pharmaceuticals, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Rhythmlink, SoftBox Systems, ZEUS, Patheon Thermo Fisher, Zverse, Abbott, Alcami and more. All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are represented, as are major healthcare systems, and economic development entities including the South Carolina Department of Commerce, SCRA, South Carolina Hospital Association and others.
As the official state affiliate of BIO, PhRMA and AdvaMed, SCBIO members include academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.
For additional information on SCBIO or to register for SCBIO 2021, visit www.SCBIO.org.
Life Sciences is front and center in this fabulous podcast see more
Heather Matthews and and Matthew Roberts of the Nexsen Pruet healthcare practice group's Taking the Pulse podcast are joined by special co-host Nexsen Pruet attorney Tushar Chikhliker for a crossover episode with The Buzz: an Economic Development Podcast to introduce SCBIO's new leader, James Chappell.
After a nationwide search, James has recently been named as SCBIO’s new President & CEO to lead the organization’s great work in directing the flourishing life sciences industry in South Carolina. Enjoy this special episode to learn about James Chappell, the future of life sciences in the state and SCBIO’s development efforts at building the business of life sciences across the Palmetto State. Listen to the podcast now.
SCBIO Names Louisiana Economic Development Executive James Chappell as CEO to Lead State’s Fastest-Growing IndustryGoal to “take South Carolina life sciences to an entirely new level” see more
Following a nationwide search that targeted 200 candidates in 39 states and resulted in 116 total applications from across the country, the Board of Directors of SCBIO has named James Chappell, an executive with Louisiana Economic Development, as the organization’s new President and Chief Executive Officer.
Dr. Chappell, whose career also includes time with Chartic Management Consulting in Boston, joined Louisiana Economic Development (LED) in 2013 and held positions of increasing responsibility at the organization including Executive Director of State Economic Competitiveness before being named Executive Director of Competitiveness and Entrepreneurship for the organization in 2021.
During his tenure at LED, Dr. Chappell’s numerous successes included designing and implementing the state’s $100 million venture capital and small business funds, developing strategies to recruit globally recognized companies to the state , and joining the Louisiana MediFund board to develop strategies to increase the biosciences and healthcare industries in Louisiana. He also collaborated with bioscience and technology advocates to improve incentives to promote growth in the bioscience and technology industries.
Dr Chappell earned his B.S. and M.S. in Plant Environmental Sciences from Clemson University, his Ph.D. from Louisiana State University, and a Postdoctoral Fellowship in Stem Cell Biology focusing on cancer and diabetes from Harvard Medical School. A three-year varsity football letterman while at Clemson, he is married with two children. He will begin his new role with SCBIO starting November 8, 2021.
“SCBIO and South Carolina life sciences are excited to welcome James to lead this dynamic and forward-looking industry organization, and to help our hundreds of life sciences companies and thousands of employees and innovators take it to an entirely new level,” said Lou Kennedy, Board Chair of SCBIO and founder and CEO of Nephron Pharmaceuticals, and a member of the search committee. “Competition for the position was extremely strong but we unanimously felt that his credentials in both life sciences and economic development were the precise mix we sought as we continue to build, advance and grow the industry in South Carolina.”
Life sciences has a $12 billion economic impact in the Palmetto State, with more than 700 firms involved and over 43,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental, and agricultural biotechnology products. It also represents a significant economic development focus for the state, led by the South Carolina Department of Commerce and other regional economic development teams.
South Carolina life sciences has seen a near-doubling of firms and 40% increase in life sciences’ direct employment since 2017, which combine to make it the fastest growing industry sector in the state, according to data provided by Dr. Joseph Von Nessen, state research economist and noted economic development expert with the Moore School of Business at the University of South Carolina.
“As a South Carolina native, I am thrilled to join SCBIO and return home. South Carolina has become an emerging leader in life sciences, and I am excited to continue SCBIO’s great work in helping to grow the life sciences industry,” noted Dr. Chappell.
Ms. Kennedy went on to thank SCBIO Interim CEO Erin Ford for her critical contributions in leading the organization during the search process, which began in May with the resignation of prior CEO Sam Konduros.
“Erin continued to do a strong and stellar job in leading the organization, charting the path, and maintaining the momentum without missing a beat during this national search, and our board and membership are grateful to her. The entire board and SCBIO membership are excited that she will remain a key part of the organization in her prior role of Executive Vice President and COO to add a steady and experienced hand to crafting an exciting new future.”
Ms. Ford has served as primary lead for SCBIO’s business operations and finances, championing investor relations and existing industry strategies, and spearheading integrated marketing initiatives. She has managed the majority of the organization’s day-to-day requirements since joining SCBIO in 2017.
Since 2017, SCBIO has more than tripled membership and quadrupled revenues, implemented a strong economic development focus, and launched a new innovation platform. It serves as the voice of the life sciences industry, implemented a surging workforce development initiative and created ongoing programs to encourage participation by women in life sciences, to support diversity-equity-inclusion initiatives and to encourage student participation in the industry. The organization also successfully led industry and organizational pivots during the COVID pandemic. In a recent executive order, Governor Henry McMaster authorized SCBIO and the state’s Commerce Department to work together to accelerate the onshoring and repatriation of the pharmaceutical industry and vital PPE products and technologies to South Carolina.
For additional information on SCBIO, please visit www.SCBIO.org.